Aims and Scope
Biomarkers in Cancer is an open access, peer reviewed electronic journal focusing on all aspects of cancer and biomarkers.
Biomarkers in Cancer seeks to be the most timely journal for those who need to be up to date with the latest and most important developments in the field. The journal offers high-speed and credible submission processing to authors. At a time when institutional libraries are aggressively cutting subscriptions to conventional journals, by publishing in the open access format authors are able to reach the widest possible group of authors.
Standard Author Services
The journal distinguishes itself from others in the field by combining individualized author service with editorial integrity and procedural efficiency. At every stage authors will be introduced to the staff member responsible for their paper and will receive procedural explanations and regular status updates. The progress of authors’ papers is continually monitored by staff, and a staff member is always available to answer authors' questions. This is reflected in our consistently positive author testimonials.
Submission to first editorial decision including rigorous, expert peer review in average four weeks
Rapid publication in two to four weeks after acceptance
No deadlines for corrections to typeset proofs
Paper announcement after publication through scholarly databases, social media, and opted-in newsletters
Open access visibility and flexibility with no restrictions on author archiving
CC-BY-NC licensing to prohibit unrestricted commercial re-use, CC-BY available on request
Article level usage metrics (in beta)
Permanent availability by leading institutional libraries under CLOCKSS and LOCKSS systems
Proactive, professional journal staff
Optional Author Services
Discounted article reprints
English proof reading
Pre-submission paper-matching and editor in chief consultation
Pre-peer review language polishing and paper formatting
Video abstracts
Ebook on enhancing article visibility
Social media promotion
Current Article Processing Fees
As an open access journal authors are charged an article processing fee after acceptance for publication by the editor in chief or associate editor. Fees do not vary based on factors like word count or use of color images, and there is no fee charged upon submission. Current fees are given below:
Authors in North America: US$1848
Authors in Japan: ¥220,500
Authors in other countries: €1549
More information on article processing fees and availability of waivers and discounts are available on the article processing fees webpage.
Manuscript Types and Preparation Guidelines
Information on manuscript types accepted for peer review and guidelines for manuscript preparation are available here. A template manuscript, sample manuscript, and pre-submission check list are available here.
Editorial Policies
All articles are subject to blind independent peer review by reviewers drawn from the journal's editorial board, volunteer peer reviewer pool, and where necessary from Pubmed. Pubmed is used where specialized expertise is unavailable from the other sources. Two to four peer reviewers will be used. Editorial decisions are made by independent editors in chief or associate editors. The editorial process from peer review to first editorial decision takes three to four weeks following acceptance of each paper for peer review.
In the open access business model many editorial decisions result in a fee payment to the publisher. Because of this we maintain a strict distinction between editorial decisions, made by editors in chief or associate editors, and business decisions. Libertas does not make nor attempt to influence editorial decisions. Editorial decision makers receive no incentives to make decisions leading to fee payments.
The journal is committed to high standards of integrity. Authors are required to confirm their compliance with ethical and legal requirements upon submission. Prior to publication all authors must provide signed confirmation of compliance. Where concerns arise the journal will apply the Committee on Publication Ethics guidelines on ethical matters.
Frequency of Publication
Articles are published upon completion of production.
Citing Articles
Article citations follow this format:
Authors: Title. Journal [year]:[volume] [first page]-[last page]
Open Access
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
Inquiries
Correspondence should be sent to . Contact details for Libertas staff are available here.
Additional Information for Authors
As Editor-in-Chief of Biomarkers in Cancer I wanted to know what it is like to publish in my own journal. I have already published over 70 papers, so I knew what a range of other journals were like. I was impressed by the quality of the reviewers comments which made the paper so much better before it was accepted for publication. I was pleasantly surprised by how quickly the article went from acceptance to published, ...
Facebook Google+ Twitter
Pinterest Tumblr YouTube